Literature DB >> 16234979

Self-assembled RANK induces osteoclastogenesis ligand-independently.

Kiyoshi Kanazawa1, Akira Kudo.   

Abstract

UNLABELLED: By immunoprecipitation assay, we showed that mouse RANK was self-assembled through its cytoplasmic domain located at position 534-539, whose domain was different form TRAF binding domains. Moreover, overexpression experiments showed that oligomeric RANK, which was self-associated, induced osteoclastogenesis ligand-independently.
INTRODUCTION: TNF receptor I or II (TNF-RI or TNF-RII) is thought to induce its own trimerization by ligand binding; however, recently TNF-RI or TNF-RII was shown to form a trimer through its extracellular domain without ligand binding. RANK, which plays an important role in osteoclast differentiation, is a member of the TNF receptor family. Here, we studied the self-assembly of mouse RANK.
MATERIALS AND METHODS: Self-assembly of mouse RANK was examined by immunoprecipitation assay using 293T cells that had been transfected with the full-length RANK (Full) fused to FLAG tag (Full-FLAG) and Full fused to HA tag (Full-HA) without soluble RANKL (sRANKL). To explore the binding site for self-assembly, FLAG-tagged RANK C-terminal deletion mutants, 461-, 511-, 533-, 539-, and 544-FLAG, were constructed, and immunoprecipitation was performed. To examine whether RANK overexpression induced osteoclastogenesis, osteoclast progenitors that were derived from wildtype bone marrow cells, in which RANK was overexpressed, were cultured with monocyte-macrophage colony-stimulating factor (M-CSF), and TRACP staining was performed. We examined whether overexpression of each five individual C-terminal mutants induced osteoclastogenesis in osteoclast progenitors. To study the involvement of TRAF6 in RANK-induced osteoclastogenesis, osteoclast progenitors, in which RANK was overexpressed, were cultured with M-CSF and TNF receptor-associated factor (TRAF)6 decoy peptides (T6DP) that inhibit the interaction of RANK with TRAF6. RESULTS AND
CONCLUSIONS: Immunoprecipitation experiments showed that RANK was self-assembled without sRANKL. Among the five individual mutants, only 539- and 544-FLAG mutants were associated with Full-HA ligand-independently, suggesting that self-association of RANK was regulated by its cytoplasmic domain located at position 534-539. Overexpression of full-length RANK induced osteoclast differentiation, and this differentiation was suppressed by treatment with T6DP. Overexpression of RANK deletion mutants revealed that only 539- and 544-FLAG induced osteoclastogenesis. The five C-terminal mutants had the TRAF6 binding domain in their cytoplasmic regions, suggesting that ligand-independent osteoclastogenesis requires the receptor oligomerization of RANK.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234979     DOI: 10.1359/JBMR.050706

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

Review 1.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Cluster formation of anchored proteins induced by membrane-mediated interaction.

Authors:  Shuangyang Li; Xianren Zhang; Wenchuan Wang
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

3.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

Review 4.  Mechanisms of RANKL delivery to the osteoclast precursor cell surface.

Authors:  Masashi Honma; Yuki Ikebuchi; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2020-10-12       Impact factor: 2.626

Review 5.  Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.

Authors:  David L Lacey; William J Boyle; W Scott Simonet; Paul J Kostenuik; William C Dougall; John K Sullivan; Javier San Martin; Roger Dansey
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

6.  Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Authors:  Matteo M Guerrini; Cristina Sobacchi; Barbara Cassani; Mario Abinun; Sara S Kilic; Alessandra Pangrazio; Daniele Moratto; Evelina Mazzolari; Jill Clayton-Smith; Paul Orchard; Fraser P Coxon; Miep H Helfrich; Julie C Crockett; David Mellis; Ashok Vellodi; Ilhan Tezcan; Luigi D Notarangelo; Michael J Rogers; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Journal:  Am J Hum Genet       Date:  2008-07       Impact factor: 11.025

7.  Interplay between low plasma RANKL and VDR-FokI polymorphism in lumbar disc herniation independently from age, body mass, and environmental factors: a case-control study in the Italian population.

Authors:  Veronica Sansoni; Silvia Perego; Alessandra Colombini; Giuseppe Banfi; Marco Brayda-Bruno; Giovanni Lombardi
Journal:  Eur Spine J       Date:  2015-08-11       Impact factor: 3.134

8.  Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.

Authors:  Anastasios D Papanastasiou; Chaido Sirinian; Haralabos P Kalofonos
Journal:  Breast Cancer Res       Date:  2012-07-23       Impact factor: 6.466

9.  Signal peptide mutations in RANK prevent downstream activation of NF-κB.

Authors:  Julie C Crockett; David J Mellis; Kathleen Ij Shennan; Angela Duthie; John Greenhorn; Debbie I Wilkinson; Stuart H Ralston; Miep H Helfrich; Michael J Rogers
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

10.  TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.

Authors:  Sharron A N Brown; Emily Cheng; Mark S Williams; Jeffrey A Winkles
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.